Pivotal bioVenture Partners Investment Advisor LLC Long-Term Concentrated

CIK: 0001844645 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 13, 2024

Total Value ($000): $130,067 (100.0% shares, 0.0% debt)

Holdings (10)

PCVX VAXCYTE INC 46.0%

Value ($000) $59,882 Shares 793,036 Est. Cost $38.47 Unrealized +77.0%

— INOZYME PHARMA INC 15.4%

Value ($000) $20,047 Shares 4,494,851 Est. Cost $10.48 Unrealized —

OCS OCULIS HOLDING AG 14.7%

Value ($000) $19,071 Shares 1,595,918 Est. Cost $9.59 Unrealized +24.2%

ARQT ARCUTIS BIOTHERAPEUTICS INC 14.6%

Value ($000) $18,982 Shares 2,041,108 Est. Cost $11.32 Unrealized -20.1%

— EXSCIENTIA PLC 3.0%

Value ($000) $3,930 Shares 770,500 Est. Cost $19.76 Unrealized —

— RALLYBIO CORP 2.5%

Value ($000) $3,222 Shares 2,404,644 Est. Cost $16.97 Unrealized —

— VIGIL NEUROSCIENCE INC 1.7%

Value ($000) $2,242 Shares 560,595 Est. Cost $7.03 Unrealized —

— BOLT BIOTHERAPEUTICS INC 1.1%

Value ($000) $1,419 Shares 1,891,467 Est. Cost $32.91 Unrealized —

IOBT IO BIOTECH INC 0.8%

Value ($000) $1,011 Shares 864,197 Est. Cost $1.76 Unrealized -20.5%

— ALIGOS THERAPEUTICS INC 0.2%

Value ($000) $260 Shares 743,215 Est. Cost $27.65 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PCVX	VAXCYTE INC	793,036	$59,882	46.0%	$38.47	+77.0%	COM	92243G108
—	INOZYME PHARMA INC	4,494,851	$20,047	15.4%	$10.48	—	COM	45790W108
OCS	OCULIS HOLDING AG	1,595,918	$19,071	14.7%	$9.59	+24.2%	ORDINARY SHARES	H5870P102
ARQT	ARCUTIS BIOTHERAPEUTICS INC	2,041,108	$18,982	14.6%	$11.32	-20.1%	COM	03969K108
—	EXSCIENTIA PLC	770,500	$3,930	3.0%	$19.76	—	ADS	30223G102
—	RALLYBIO CORP	2,404,644	$3,222	2.5%	$16.97	—	COM	75120L100
—	VIGIL NEUROSCIENCE INC	560,595	$2,242	1.7%	$7.03	—	COM	92673K108
—	BOLT BIOTHERAPEUTICS INC	1,891,467	$1,419	1.1%	$32.91	—	COM	097702104
IOBT	IO BIOTECH INC	864,197	$1,011	0.8%	$1.76	-20.5%	COM	449778109
—	ALIGOS THERAPEUTICS INC	743,215	$260	0.2%	$27.65	—	COM	01626L105